Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.

MLA

Nakajima, Shotaro, et al. “Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.” Molecular Cancer Research : MCR, vol. 19, no. 6, June 2021, pp. 1085–95. EBSCOhost, https://doi.org/10.1158/1541-7786.MCR-20-0917.

APA

Nakajima, S., Mimura, K., Saito, K., Thar Min, A. K., Endo, E., Yamada, L., Kase, K., Yamauchi, N., Matsumoto, T., Nakano, H., Kanke, Y., Okayama, H., Saito, M., Neupane, P., Saze, Z., Watanabe, Y., Hanayama, H., Hayase, S., Kaneta, A., … Kono, K. (2021). Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma. Molecular Cancer Research : MCR, 19(6), 1085–1095. https://doi.org/10.1158/1541-7786.MCR-20-0917

Chicago

Nakajima, Shotaro, Kosaku Mimura, Katsuharu Saito, Aung Kyi Thar Min, Eisei Endo, Leo Yamada, Koji Kase, et al. 2021. “Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.” Molecular Cancer Research : MCR 19 (6): 1085–95. doi:10.1158/1541-7786.MCR-20-0917.